E2F transcriptional repressor complexes are critical downstream targets of p19ARF/p53-induced proliferative arrest
Open accessAbstract
The p16(INK4a)/pRB/E2F and p19(ARF)/p53 tumor suppressor pathways are disrupted in most human cancers. Both p19(ARF) and p53 are required for the induction of senescence in primary mouse embryonic fibroblasts (MEFs), but little is known about their downstream targets. Disruption of E2F-mediated transcriptional repression in MEFs caused a general increase in the expression of E2F target genes, including p19ARF. We detected no contribution of E2F-mediated transactivation in this setting, indicating that a predominant role of endogenous E2F in asynchronously growing primary MEFs is to repress its target genes. Moreover, relief of transcriptional repression by E2F rendered MEFs resistant to senescence induced by either p19(ARF), p53, or RAS(V12). Thus, E2F transcriptional repressor complexes are critical downstream targets of antiproliferative p19(ARF)/p53 signaling.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mouse, but not human, p19ARF is upregulated by various oncogenes (e.g., Ras and E2F), leading to p53 activation and senescence.
“Notably, mouse, but not human, p19ARF is upregulated by various oncogenes (e.g., Ras and E2F), leading to p53 activation and senescence [125,126].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [126]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · see citing works
The limited in vitro lifetime of human diploid cell strains
Hayflick, L. (1965) · Experimental Cell Research · doi:10.1016/0014-4827(65)90211-9 · Cited by 5,876 · see citing works
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,178 · cited 3× · see citing works
“Then, cells were permeabilized and stained withation of ecotropic retroviruses (Serrano et al., 1997).”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · see citing works
Atmospheric carbon dioxide concentrations over the past 60 million years
Pearson, P. N., & Palmer, M. R. (2000) · Nature · doi:10.1038/35021000 · Cited by 1,771 · see citing works
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626 · see citing works
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566 · see citing works
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521 · see citing works
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485 · see citing works
Essential role of mouse telomerase in highly proliferative organs
Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., & DePinho, R. A. (1998) · Nature · doi:10.1038/33345 · Cited by 1,270 · see citing works
The Rb/E2F pathway: expanding roles and emerging paradigms
Harbour, J. W., & Dean, D. C. (2000) · Genes & Development · doi:10.1101/gad.813200 · Cited by 1,153 · see citing works
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057 · see citing works
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943 · see citing works
Nucleolar Arf sequesters Mdm2 and activates p53
Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J., & Bar-Sagi, D. (1999) · Nature Cell Biology · doi:10.1038/8991 · Cited by 940 · see citing works
p14ARF links the tumour suppressors RB and p53
Bates, S., Phillips, A. C., Clark, P. A., Stott, F., Peters, G., Ludwig, R. L., & Vousden, K. H. (1998) · Nature · doi:10.1038/25867 · Cited by 918 · see citing works
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
Lukas, J., Parry, D., Aagaard, L., Mann, D. J., Bartkova, J., Strauss, M., Peters, G., & Bartek, J. (1995) · Nature · doi:10.1038/375503a0 · Cited by 899 · see citing works
Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis
Sharpless, N. E., Bardeesy, N., Lee, K.-H., Carrasco, D., Castrillon, D. H., Aguirre, A. J., Wu, E. A., Horner, J. W., & DePinho, R. A. (2001) · Nature · doi:10.1038/35092592 · Cited by 848 · see citing works
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M. A., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 838 · see citing works
p53 and E2F-1 cooperate to mediate apoptosis.
Wu, X., & Levine, A. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3602 · Cited by 836 · see citing works
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties
Kaelin, W. G., Krek, W., Sellers, W. R., DeCaprio, J. A., Ajchenbaum, F., Fuchs, C. S., Chittenden, T. D., Li, Y., Farnham, P., Blanar, M. A., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90108-o · Cited by 819 · see citing works
Vousden, K. H. (2000) · Cell · doi:10.1016/s0092-8674(00)00171-9 · Cited by 785 · see citing works
Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis.
Qin, X. Q., Livingston, D. M., Kaelin, W. G., & Adams, P. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10918 · Cited by 753 · see citing works
Sherr, C. J., & DePinho, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)00046-5 · Cited by 745 · see citing works
Tumor surveillance via the ARF–p53 pathwayPreprint
Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.19.2984 · Cited by 716 · see citing works
Distinct roles for E2F proteins in cell growth control and apoptosis
DeGregori, J. V., Leone, G. W., Miron, A., Jakoi, L., & Nevins, J. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7245 · Cited by 704 · see citing works
Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W., & Dean, D. C. (2000) · Cell · doi:10.1016/s0092-8674(00)80625-x · Cited by 658 · see citing works
The E2F1–3 transcription factors are essential for cellular proliferation
Wu, L., Timmers, C. D., Maiti, B., Saavedra, H. I., Sang, L., Chong, G. T., Nuckolls, F., Giangrande, P. H., Wright, F. A., Field, S. J., et al. (2001) · Nature · doi:10.1038/35106593 · Cited by 620 · see citing works
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 617 · see citing works
A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F
Helin, K., Lees, J. A., Vidal, M., Dyson, N. J., Harlow, E., & Fattaey, A. (1992) · Cell · doi:10.1016/0092-8674(92)90107-n · Cited by 613 · see citing works
Analysis of Chromatin Structure byin VivoFormaldehyde Cross-Linking
Orlando, V., Strutt, H. L., & Paro, R. (1997) · Methods · doi:10.1006/meth.1996.0407 · Cited by 607 · see citing works
Interaction between the retinoblastoma protein and the oncoprotein MDM2
Xiao, Z.-X., Chen, J., Levine, A. J., Modjtahedi, N., Xing, J. W., Sellers, W. R., & Livingston, D. M. (1995) · Nature · doi:10.1038/375694a0 · Cited by 586 · see citing works
Sage, J., Mulligan, G. J., Attardi, L. D., Miller, A., Chen, S., Williams, B., Theodorou, E., & Jacks, T. (2000) · Genes & Development · doi:10.1101/gad.843200 · Cited by 582 · see citing works
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · see citing works
PML is induced by oncogenic <i>ras</i> and promotes premature senescence
Ferbeyre, G., de Stanchina, E., Querido, E., Baptiste, N., Prives, C., & Lowe, S. W. (2000) · Genes & Development · doi:10.1101/gad.14.16.2015 · Cited by 536 · see citing works
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
Koh, J., Enders, G. H., David Dynlacht, B., & Harlow, E. (1995) · Nature · doi:10.1038/375506a0 · Cited by 516 · see citing works
Krek, W. (1994) · Cell · doi:10.1016/0092-8674(94)90582-7 · Cited by 495 · see citing works
Johnson, D. G., Ohtani, K., & Nevins, J. R. (1994) · Genes & Development · doi:10.1101/gad.8.13.1514 · Cited by 494 · see citing works
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491 · see citing works
Inhibition of E2F-1 Transactivation by Direct Binding of the Retinoblastoma Protein
Helin, K., Harlow, E. E., & Fattaey, A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6501 · Cited by 472 · see citing works
Growth suppression by p16ink4 requires functional retinoblastoma protein
Medema, R. H., Herrera, R. E., Lam, F., & Weinberg, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.14.6289 · Cited by 433 · see citing works
Kowalik, T. F., DeGregori, J. V., Schwarz, J., & Nevins, J. R. (1995) · Journal of Virology · doi:10.1128/jvi.69.4.2491-2500.1995 · Cited by 418 · see citing works
Dannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413 · see citing works
Welch, P. J. (1993) · Cell · doi:10.1016/0092-8674(93)90497-e · Cited by 407 · see citing works
Dimri, G. P., Itahana, K., Acosta, M., & Campisi, J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.273-285.2000 · Cited by 393 · see citing works
Failure to Phosphorylate the Retinoblastoma Gene Product in Senescent Human Fibroblasts
Stein, G. H., Beeson, M., & Gordon, L. (1990) · Science · doi:10.1126/science.2166342 · Cited by 370 · see citing works
p53-independent functions of the p19ARF tumor suppressorPreprint
Weber, J. D., Jeffers, J. R., Rehg, J. E., Randle, D. H., Lozano, G., Roussel, M. F., Sherr, C. J., & Zambetti, G. P. (2000) · Genes & Development · doi:10.1101/gad.827300 · Cited by 355 · see citing works
Krek, W., Xu, G., & Livingston, D. M. (1995) · Cell · doi:10.1016/0092-8674(95)90141-8 · Cited by 354 · see citing works
Zhang, H. S., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)80714-x · Cited by 349 · see citing works
Zhang, Y., & Xiong, Y. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80351-2 · Cited by 347 · see citing works
Botquin, V., Hess, H., Fuhrmann, G., Anastassiadis, K., Gross, M. K., Vriend, G., & Schöler, H. R. (1998) · Genes & Development · doi:10.1101/gad.12.13.2073 · Cited by 314 · see citing works
Herrera, R. E., Sah, V. P., Williams, B. O., Mäkelä, T. P., Weinberg, R. A., & Jacks, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.5.2402 · Cited by 302 · see citing works
E2F4 and E2F5 Play an Essential Role in Pocket Protein–Mediated G1 Control
Gaubatz, S., Lindeman, G. J., Ishida, S., Jakoi, L., Nevins, J. R., Livingston, D. M., & Rempel, R. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00071-x · Cited by 300 · see citing works
p16INK4A and p19ARF act in overlapping pathways in cellular immortalization
Carnero, A., Hudson, J. D., Price, C. M., & Beach, D. (2000) · Nature Cell Biology · doi:10.1038/35004020 · Cited by 278 · see citing works
Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278 · see citing works
The E2F transcription factors: key regulators of cell proliferation
Müller, H., & Helin, K. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00030-x · Cited by 259 · see citing works
Sellers, W. R., Rodgers, J. W., & Kaelin, W. G. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11544 · Cited by 250 · see citing works
Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.Preprint
Beijersbergen, R. L., Carlée, L., Kerkhoven, R. M., & Bernards, R. (1995) · Genes & Development · doi:10.1101/gad.9.11.1340 · Cited by 248 · see citing works
Self-citationNeuman, E., Flemington, E. K., Sellers, W. R., & Kaelin, W. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4660 · Cited by 247 · see citing works
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.Preprint
Hsiao, K., McMahon, S., & Farnham, P. (1994) · Genes & Development · doi:10.1101/gad.8.13.1526 · Cited by 240 · see citing works
E2F-6, a member of the E2F family that can behave as a transcriptional repressor
Trimarchi, J. M., Fairchild, B., Verona, R. I., Moberg, K. H., Andon, N. L., & Lees, J. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.2850 · Cited by 223 · see citing works
Pantoja, C., & Serrano, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202880 · Cited by 201 · cited 1× · see citing works
“…still undergo RASV12- or p19ARF-induced arrest, p21CIP1 likely is not a critical p19ARF/p53 target gene in(Bruce et al., 2000; Koh et al., 1995; Lukas et al., 1995; Medema et al., 1995). p19ARF, too, is a tumor suppressor gene that has this setting (Groth et al., 2000; Pantoja and Serrano, 1999).”
BackgroundE2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription
Cartwright, P., Müller, H., Wagener, C., Holm, K., & Helin, K. (1998) · Oncogene · doi:10.1038/sj.onc.1201975 · Cited by 189 · see citing works
The Transcription Factor E2F-1 Is a Downstream Target of RB Action
Qin, X.-Q., Livingston, D. M., Ewen, M. E., Sellers, W. R., Arany, Z. P., & Kaelin, W. G. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.2.742 · Cited by 188 · see citing works
Gaubatz, S., Wood, J. G., & Livingston, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9190 · Cited by 180 · see citing works
p19ARF targets certain E2F species for degradation
Martelli, F., Hamilton, T., Silver, D. P., Sharpless, N. E., Bardeesy, N. M., Rokas, M., DePinho, R. A., Livingston, D. M., & Grossman, S. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081061398 · Cited by 167 · see citing works
The Promyelocytic Leukemia Gene Product (PML) Forms Stable Complexes with the Retinoblastoma Protein
Alcalay, M., Tomassoni, L., Colombo, E., Stoldt, S., Grignani, F., Fagioli, M., Székely, L., Helin, K., & Pelicci, P. G. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.2.1084 · Cited by 160 · see citing works
Requirements for Cell Cycle Arrest by p16INK4a
Bruce, J. L., Hurford, R. K., Classon, M., Koh, J., & Dyson, N. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00072-1 · Cited by 146 · see citing works
Neuman, E., Flemington, E. K., Sellers, W. R., & Kaelin, W. G. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6607 · Cited by 144 · see citing works
The role of cyclin E in cell proliferation, development and cancer
Keyomarsi, K., & Herliczek, T. W. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_14 · Cited by 135 · see citing works
The transcription factor E2F-1 mediates the autoregulation of RB gene expression
Shan, B., Chang, C.-Y., Jones, D., & Lee, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.1.299-309.1994 · Cited by 128 · see citing works
Shan, B., Durfee, T. J., & Lee, W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.2.679 · Cited by 123 · see citing works
Regulation of two E2F-related genes in presenescent and senescent human fibroblasts.
Dimri, G. P., Hara, E., & Campisi, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33990-x · Cited by 122 · see citing works
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence
Peeper, D. S., Shvarts, A., Brummelkamp, T. R., Douma, S., Koh, E. Y., Daley, G. Q., & Bernards, R. (2002) · Nature Cell Biology · doi:10.1038/ncb742 · Cited by 110 · see citing works
Self-citationEscape from premature senescence is not sufficient for oncogenic transformation by Ras
Peeper, D. S., Dannenberg, J., Douma, S., Riele, H. T., & Bernards, R. (2001) · Nature Cell Biology · doi:10.1038/35055110 · Cited by 103 · see citing works
Self-citationGroth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003417200 · Cited by 92 · see citing works
Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
Johnson, D. G. (1995) · PubMed · Cited by 73 · see citing works
Haddad, M. M., Xu, W., Schwahn, D. J., Liao, F., & Medrano, E. E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4688 · Cited by 62 · see citing works
Helin, K., & Harlow, E. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5027-5035.1994 · Cited by 58 · see citing works
E2F Is Required To Prevent Inappropriate S-Phase Entry of Mammalian Cells
He, S., Cook, B. L., Deverman, B. E., Weihe, U., Zhang, F., Prachand, V. N., Zheng, J., & Weintraub, S. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.363-371.2000 · Cited by 43 · see citing works
Endogenous E2F-1 promotes timely G 0 exit of resting mouse embryo fibroblasts
Wang, Z., Yang, H., & Livingston, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15583 · Cited by 33 · see citing works
Flagged first, then by citations
1 of the 81 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690 · see citing works
Cellular senescence and tumor suppressor gene p16
Rayess, H., Wang, M. B., & Srivatsan, E. S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27316 · Cited by 825 · see citing works
Tumor suppression by Ink4a-Arf: progress and puzzles.
Lowe, S. W., & Sherr, C. J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00013-8 · Cited by 699 · see citing works
Kortlever, R. M., Higgins, P. J., & Bernards, R. (2006) · Nature Cell Biology · doi:10.1038/ncb1448 · Cited by 637 · see citing works
Self-citationDivorcing ARF and p53: an unsettled case
Sherr, C. J. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1954 · Cited by 595 · see citing works
Rowland, B. D., Bernards, R., & Peeper, D. S. (2005) · Nature Cell Biology · doi:10.1038/ncb1314 · Cited by 583 · see citing works
Self-citationThe E2F family: specific functions and overlapping interests
Attwooll, C. L., Denchi, E. L., & Helin, K. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600481 · Cited by 568 · see citing works
p53 and E2f: partners in life and death
Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498 · see citing works
Role of the proto-oncogene Pokemon in cellular transformation and ARF repression
Maeda, T., Hobbs, R. M., Merghoub, T., Guernah, I., Zelent, A., Cordon‐Cardo, C., Teruya‐Feldstein, J., & Pandolfi, P. P. (2005) · Nature · doi:10.1038/nature03203 · Cited by 399 · see citing works
Mechanisms and Regulation of Cellular Senescence
Roger, L., Tomas, F., & Gire, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313173 · Cited by 395 · see citing works
Emerging roles for E2F: Beyond the G1/S transition and DNA replication
Cam, H. P., & Dynlacht, B. D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00080-1 · Cited by 344 · see citing works
Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin
Gonzalo, S., García-Cao, M., Fraga, M. F., Schotta, G., Peters, A. H. F. M., Cotter, S. E., Eguía, R., Dean, D. C., Esteller, M., Jenuwein, T., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1235 · Cited by 343 · see citing works
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326 · see citing works
E2F – at the crossroads of life and death
Polager, S., & Ginsberg, D. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.08.003 · Cited by 300 · see citing works
p53 Family and Cellular Stress Responses in Cancer
Pflaum, J., Schlosser, S., & ller, M. M. ⁄. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00285 · Cited by 294 · see citing works
Reversal of Senescence in Mouse Fibroblasts through Lentiviral Suppression of p53
Dirac, A. M. G., & Bernards, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300023200 · Cited by 254 · see citing works
Self-citationCellular senescence and cancer treatment
Schmitt, C. A. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.005 · Cited by 254 · see citing works
Taubert, S., Gorrini, C., Frank, S. R., Parisi, T., Fuchs, M., Chan, H., Livingston, D. M., & Amati, B. B. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.10.4546-4556.2004 · Cited by 221 · see citing works
Targeting the RB-E2F pathway in breast cancer
Johnson, J., Thijssen, B., McDermott, U., Garnett, M. J., Wessels, L. F. A., & Bernards, R. (2016) · Oncogene · doi:10.1038/onc.2016.32 · Cited by 198 · see citing works
Self-citationActivation of nuclear factor-kappa B signalling promotes cellular senescence
Rovillain, E. M. I., Mansfield, L., Caetano, C., Álvarez‐Fernández, M., Caballero, O. L., Medema, R. H., Hummerich, H., & Jat, P. (2011) · Oncogene · doi:10.1038/onc.2010.611 · Cited by 197 · see citing works
Regulating the p53 system through ubiquitination
Yang, Y., Li, C.-C. H., & Weissman, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207411 · Cited by 179 · see citing works
Regulation of E2Fs and senescence by PML nuclear bodies
Vernier, M., Bourdeau, V., Gaumont-Leclerc, M.-F., Moiseeva, O., Bégin, V., Saad, F., Mes-Masson, A.-M., & Ferbeyre, G. (2011) · Genes & Development · doi:10.1101/gad.1975111 · Cited by 177 · see citing works
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kineticsPreprint
Aslanian, A., Iaquinta, P. J., Verona, R. I., & Lees, J. A. (2004) · Genes & Development · doi:10.1101/gad.1196704 · Cited by 170 · see citing works
C/EBPβ cooperates with RB:E2F to implement RasV12‐induced cellular senescence
Sebastian, T. B., Malı́k, R., Thomas, S., Sage, J., & Johnson, P. F. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600789 · Cited by 147 · see citing works
Cellular Senescence as the Causal Nexus of Aging
Bhatia‐Dey, N., Kanherkar, R. R., Stair, S. E., Makarev, E., & Csoka, A. B. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00013 · Cited by 147 · see citing works
Dick, F. A., & Dyson, N. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00344-7 · Cited by 142 · see citing works
Zou, X., Ray, D., Aziyu, A., Christov, K. T., Boiko, A. D., Gudkov, A. V., & Kiyokawa, H. (2002) · Genes & Development · doi:10.1101/gad.1033002 · Cited by 143 · see citing works
Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T., & Takahashi, C. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.001 · Cited by 140 · see citing works
A kinase shRNA screen links LATS2 and the pRB tumor suppressorPreprint
Tschöp, K., Conery, A. R., Litovchick, L., DeCaprio, J. A., Settleman, J. E., Harlow, E., & Dyson, N. J. (2011) · Genes & Development · doi:10.1101/gad.2000211 · Cited by 125 · see citing works
Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor
Sreeramaneni, R., Chaudhry, A., McMahon, M., Sherr, C. J., & Inoue, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.220-232.2005 · Cited by 121 · see citing works
Retinoblastoma Tumor Suppressor: Where Cancer Meets the Cell Cycle
Knudsen, E. S., & Knudsen, K. E. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100713 · Cited by 105 · see citing works
Timmers, C. D., Sharma, N., Opavský, R., Maiti, B., Wu, L., Wu, J. S., Orringer, D. A., Trikha, P., Saavedra, H. I., & Leone, G. W. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02147-05 · Cited by 106 · see citing works
Myc-Mediated Proliferation and Lymphomagenesis, but Not Apoptosis, Are Compromised by E2f1 Loss
Baudino, T. A., Maclean, K. H., Brennan, J. A., Parganas, E., Yang, C., Aslanian, A., Lees, J. A., Sherr, C. J., Roussel, M. F., & Cleveland, J. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00102-3 · Cited by 101 · see citing works
p53-Dependent and -Independent Functions of the Arf Tumor SuppressorPreprint
Sherr, C. J., Bertwistle, D., den Besten, W., KUO, M.-L., SUGIMOTO, M., Tago, K., Williams, R. T., Zindy, F., & Roussel, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 103 · see citing works
Re-Evaluating Cell-Cycle Regulation by E2Fs
Rowland, B. D., & Bernards, R. (2006) · Cell · doi:10.1016/j.cell.2006.11.019 · Cited by 91 · see citing works
Self-citationMacrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway
Petrenko, O., & Moll, U. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.052 · Cited by 88 · see citing works
Versatile functions of p53 protein in multicellular organisms
Chumakov, P. M. (2007) · Biochemistry (Moscow) · doi:10.1134/s0006297907130019 · Cited by 84 · see citing works
Maehara, K., Yamakoshi, K., Ohtani, N., Kubo, Y., Takahashi, A., Arase, S., Jones, N., & Hara, E. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200411093 · Cited by 83 · see citing works
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 74 · see citing works
Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 72 · see citing works
E2F-1 regulates expression of FOXO1 and FOXO3a
Nowak, K., Killmer, K., Gessner, C., & Lutz, W. (2007) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2007.04.001 · Cited by 71 · see citing works
ARF tumor suppression in the nucleolus
Maggi, L. B., Winkeler, C. L., Miceli, A. P., Apicelli, A. J., Brady, S. N., Kuchenreuther, M., & Weber, J. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.01.016 · Cited by 69 · see citing works
Inoue, K., Mallakin, A., & Frazier, D. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210226 · Cited by 67 · see citing works
p16 and ARF: activation of teenage proteins in old age
Ande, S., & Rudolph, K. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci23437 · Cited by 64 · see citing works
Cell proliferation in the absence of E2F1-3
Wenzel, P. L., Chong, J.-L., Sáenz-Robles, M. T., Ferrey, A., Hagan, J. P., Gomez, Y. M., Rajmohan, R., Sharma, N., Chen, H., Pipas, J. M., et al. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.025 · Cited by 63 · see citing works
Chemotherapy response and resistance
Lee, S., & Schmitt, C. A. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00014-x · Cited by 61 · see citing works
Impaired DNA damage checkpoint response in MIF‐deficient mice
Nemajerová, A., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601564 · Cited by 62 · see citing works
NPAT Expression Is Regulated by E2F and Is Essential for Cell Cycle Progression
Gao, G., Bracken, A. P., Burkard, K. T. D., Pasini, D., Classon, M., Attwooll, C. L., Sagara, M., Imai, T., Helin, K., & Zhao, J. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.8.2821-2833.2003 · Cited by 60 · see citing works
Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene
Chen, D., Padiernos, E., Ding, F., Lossos, I. S., & Lopez, C. D. (2004) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401536 · Cited by 59 · see citing works
Kandhaya‐Pillai, R., Miró‐Mur, F., Alijotas‐Reig, J., Tchkonia, T., Schwartz, S., Kirkland, J. L., & Oshima, J. (2023) · Aging · doi:10.18632/aging.204743 · Cited by 53 · see citing works
Talluri, S., Isaac, C. E., Ahmad, M. A. E.-R., Henley, S. A., Francis, S. M., Martens, A. L., Bremner, R., & Dick, F. A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01168-09 · Cited by 55 · see citing works
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Grandinetti, K. B., Jelinic, P., DiMauro, T., Pellegrino, J., Rodríguez, R. F., Finnerty, P. M., Ruoff, R., Bardeesy, N. M., Logan, S. K., & David, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0537 · Cited by 52 · see citing works
ORF73-Null Murine Gammaherpesvirus 68 Reveals Roles for mLANA and p53 in Virus Replication
Forrest, J. C., Paden, C. R., ALLEN, R. D., Collins, J. T., & Speck, S. H. (2007) · Journal of Virology · doi:10.1128/jvi.00111-07 · Cited by 52 · see citing works
Nijwening, J. H., Geutjes, E.-J., Bernards, R., & Beijersbergen, R. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025235 · Cited by 50 · see citing works
Self-citationSmall molecule regulators of Rb–E2F pathway as modulators of transcription
Singh, S., Johnson, J. L., & Chellappan, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.07.004 · Cited by 50 · see citing works
Melanomagenesis: Overcoming the barrier of melanocyte senescence
Ha, L., Merlino, G. T., & Sviderskaya, E. V. (2008) · Cell Cycle · doi:10.4161/cc.7.13.6230 · Cited by 46 · see citing works
Oncogene-induced senescence: An essential role for Runx
Terry, A., Cameron, E. R., Neil, J. C., & Kilbey, A. (2008) · Cell Cycle · doi:10.4161/cc.6368 · Cited by 46 · see citing works
Zheng, X., Rao, X., Gómez-Gutiérrez, J. G., Hao, H., McMasters, K. M., & Zhou, H. S. (2008) · Journal of Virology · doi:10.1128/jvi.01708-07 · Cited by 45 · see citing works
ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF
Datta, A., Sen, J., Hagen, J., Korgaonkar, C. K., Caffrey, M. S., Quelle, D. E., Hughes, D. E., Ackerson, T. J., Costa, R. H., & Raychaudhuri, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8024-8036.2005 · Cited by 45 · see citing works
Hasan, M. K., Yaguchi, T., MINODA, Y., Hirano, T., Taira, K., Wadhwa, R., & Kaul, S. C. (2004) · Biochemical Journal · doi:10.1042/bj20040337 · Cited by 44 · see citing works
RB Reversibly Inhibits DNA Replication via Two Temporally Distinct Mechanisms
Angus, S. P., Mayhew, C. N., Solomon, D. A., Braden, W. A., Markey, M. P., Okuno, Y., Cardoso, M. C., Gilbert, D. M., & Knudsen, E. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5404-5420.2004 · Cited by 44 · see citing works
Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1
Gunawardena, R. W., Siddiqui, H., Solomon, D. A., Mayhew, C. N., Held, J. D., Angus, S. P., & Knudsen, E. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400395200 · Cited by 45 · see citing works
Penzo, M., Massa, P. E., Olivotto, E., Bianchi, F., Borzı̀, R. M., Hanidu, A., Li, X., Li, J., & Marcu, K. B. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21596 · Cited by 42 · see citing works
Hemmati, P., Normand, G., Verdoodt, B., von Haefen, C., Hasenjäger, A., Güner, D., Wendt, J., Dörken, B., & Daniel, P. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208579 · Cited by 40 · see citing works
MIF loss impairs Myc-induced lymphomagenesis
Talos, F., Mena, P., Fingerle‐Rowson, G., Moll, U. M., & Petrenko, O. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401653 · Cited by 41 · see citing works
AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
Ameyar‐Zazoua, M., Wisniewska, M. B., Bakiri, L., Wagner, E. F., Yaniv, M., & Weitzman, J. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208424 · Cited by 40 · see citing works
Tavner, F. J., Frampton, J., & Watson, R. J. (2006) · Oncogene · doi:10.1038/sj.onc.1210087 · Cited by 37 · see citing works
At the stem of youth and health
Beltrami, A. P., Cesselli, D., & Beltrami, C. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.10.005 · Cited by 35 · see citing works
Angus, S. P., Solomon, D. A., Kuschel, L., Hennigan, R. F., & Knudsen, E. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8172-8188.2003 · Cited by 35 · see citing works
Expression of Dmp1 in specific differentiated, nonproliferating cells and its regulation by E2Fs
Mallakin, A., Taneja, P., Matise, L. A., Willingham, M. C., & Inoue, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209750 · Cited by 34 · see citing works
Disruption of E2F signaling suppresses the INK4a-induced proliferative defect in M33-deficient mice
Coré, N., Joly, F., Boned, A., & Djabali, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207998 · Cited by 33 · see citing works
The magnitude of methylmercury-induced cytotoxicity and cell cycle arrest is p53-dependent
Gribble, E. J., Hong, S.-W., & Faustman, E. M. (2005) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.20104 · Cited by 34 · see citing works
5‐Aza‐2'‐deoxycytidine reactivates gene expression via degradation of pRb pocket proteins
Zheng, Z., Li, L., Liu, X., Wang, D., Tu, B., Wang, L., Wang, H., & Zhu, W. (2011) · The FASEB Journal · doi:10.1096/fj.11-190025 · Cited by 32 · see citing works
Transcriptional control of the proliferation cluster by the tumor suppressor p53
Brosh, R., & Rotter, V. (2009) · Molecular BioSystems · doi:10.1039/b911416e · Cited by 30 · see citing works
Cheng, P.-H., Rao, X., McMasters, K. M., & Zhou, H. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057340 · Cited by 29 · see citing works
David-Pfeuty, T. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.08.008 · Cited by 29 · see citing works
Activating E2Fs mediate transcriptional regulation of human E2F6 repressor
Lyons, T. E., Salih, M., & Tuana, B. S. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00630.2004 · Cited by 28 · see citing works
Sinkovics, J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1248 · Cited by 27 · see citing works
Suppression of the p53-Dependent Replicative Senescence Response by Lysophosphatidic Acid Signaling
Kortlever, R. M., Brummelkamp, T. R., van Meeteren, L. A., Moolenaar, W. H., & Bernards, R. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0066 · Cited by 27 · see citing works
Self-citationJin, H., Xie, Q., Guo, X., Xu, J., Wang, A., Li, J., Zhu, J., Wu, X., Huang, H., & Huang, C. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.792010 · Cited by 26 · see citing works
Novel ARF/p53-independent senescence pathways in cancer repression
Chan, C., Gao, Y., Moten, A., & Lin, H. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0766-y · Cited by 24 · see citing works
Douglas, R. M., Farahani, R., Morcillo, P., Kanaan, A., Xu, T., & Haddad, G. G. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00520.2004 · Cited by 25 · see citing works
SUMOylation of p53 mediates interferon activities
Marcos-Villar, L., Pérez-Girón, J. V., Vilas, J. M., Soto, A., de la Cruz-Herrera, C. F., Lang, V., Collado, M., Vidal, A., Rodríguez, M. S., Muñoz‐Fontela, C., et al. (2013) · Cell Cycle · doi:10.4161/cc.25868 · Cited by 24 · see citing works
Timmers, C. D., Sharma, N., Opavský, R., Maiti, B., Wu, L., Wu, J., Orringer, D. A., Trikha, P., Saavedra, H. I., & Leone, G. W. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02147-06 · Cited by 24 · see citing works
TBX2 controls a proproliferative gene expression program in melanomaPreprint
Lu, S., Louphrasitthiphol, P., Goradia, N., Lambert, J., Schmidt, J., Chauhan, J. S., Rughani, M. G., Larue, L., Wilmanns, M., & Goding, C. R. (2021) · Genes & Development · doi:10.1101/gad.348746.121 · Cited by 21 · see citing works
Context-Dependent Requirement for dE2F during Oncogenic Proliferation
Nicolay, B., & Frolov, M. V. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000205 · Cited by 22 · see citing works
Stem cell MicroRNAs in senescence and immortalization: novel players in cancer therapy
Leal, J. A., Feliciano, A., & LLeonart, M. E. (2011) · Medicinal Research Reviews · doi:10.1002/med.20246 · Cited by 21 · see citing works
Genes and pathways involved in senescence bypass identified by functional genetic screens
Roupakia, E., Markopoulos, G. S., & Kolettas, E. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111432 · Cited by 18 · see citing works
Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence
Kumari, R., Hummerich, H., Shen, X., Fischer, M., Litovchick, L., Mittnacht, S., DeCaprio, J. A., & Jat, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01012-z · Cited by 13 · see citing works
Signal Transduction Involving the Dmp1 Transcription Factor and its Alteration in Human Cancer
Sugiyama, T., Frazier, D. P., Taneja, P., Kendig, R. D., Morgan, R. L., Matise, L. A., Lagedrost, S. J., & Inoue, K. (2008) · Clinical medicine Oncology · doi:10.4137/cmo.s548 · Cited by 13 · see citing works
RB Family Tumor Suppressor Activity May Not Relate to Active Silencing of E2F Target Genes
Vormer, T. L., Wojciechowicz, K., Dekker, M., de Vries, S., van der Wal, A., Delzenne‐Goette, E., Naik, S. H., Song, J., Dannenberg, J., Hansen, J. B., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3706 · Cited by 12 · see citing works
Genetic and epigenetic alterations in lung tumors from bitransgenic Ki‐rasG12C expressing mice
Floyd, H. S., Jennings‐Gee, J. E., Kock, N. D., & Miller, M. S. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20181 · Cited by 12 · see citing works
Magyar, Z. (2008) · Springer eBooks · doi:10.1007/7089_2007_156 · Cited by 12 · see citing works
Regulation of oncogene-induced cell cycle exit and senescence by chromatin modifiers
David, G. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.21116 · Cited by 10 · see citing works
Targeted discovery tools: proteomics and chromatin immunoprecipitation‐on‐chip
Guezennec, X. L., Brinkman, A. B., Vermeulen, M., Denissov, S., Gazziola, C., Lohrum, M. A. E., & Stunnenberg, H. G. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05942.x · Cited by 10 · see citing works
Self-citationSenescence and Cell Cycle Control
Kiyokawa, H. (2006) · Springer eBooks · doi:10.1007/400_001 · Cited by 10 · see citing works
Prindull, G. (2008) · Experimental Hematology · doi:10.1016/j.exphem.2008.07.009 · Cited by 11 · see citing works
Berns, A. J. M. (2003) · Nature · doi:10.1038/424140a · Cited by 9 · see citing works
Ricci, C., Ambrosi, F., Grillini, M., Serra, M., Melotti, B., Gruppioni, E., Altimari, A., Fiorentino, M., Dika, E., Lambertini, M., et al. (2020) · Journal of Cutaneous Pathology · doi:10.1111/cup.13802 · Cited by 8 · see citing works
E2F1 plays a direct role in Rb stabilization and p53-independent tumor suppression
Palacios, G. F., Talos, F., Nemajerová, A., Moll, U. M., & Petrenko, O. (2008) · Cell Cycle · doi:10.4161/cc.7.12.6030 · Cited by 8 · see citing works
- Authors
- Rowland, B. D., Denissov, S. G., Douma, S., Stunnenberg, H. G., Bernards, R., & Peeper, D. S.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Radboud University Nijmegen (NL)
- Corresponding author
- Bernards, René
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2002-07
- Volume
- 2
- Issue
- 1
- Pages
- 55-65
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2149068611
- Cited by
- 120
- References
- 81
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 1 · 2022: 2 · 2021: 5 · 2020: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 3 · 2013: 4 · 2012: 1
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- KWF Kankerbestrijding
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- p19ARF, p53, cellular senescence, proliferative arrest, RasV12, transcriptional repression, tumor suppressor signaling, senescence resistance
- MeSH terms
- Animals, Cell Division, DNA-Binding Proteins, Fibroblasts, Models, Genetic, Promoter Regions, Genetic, Proto-Oncogene Proteins, Genes, ras, Suppression, Genetic, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Tumor Suppressor Protein p53, 3T3 Cells, Cellular Senescence, Sequence Deletion, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, E2F Transcription Factors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review